Introduction
============

The industrial use of metallic oxide nanoparticles in a wide variety of applications has been rapidly expanding in the last decade. Such applications include the use of silicon, titanium, iron, and other metallic oxide nanoparticles, thereby increasing the occupational and other environmental exposure of these nanoparticles to humans and other species ([@b16-ijn-3-533]). Nevertheless, the health effects of exposure of humans and other species to metallic oxide nanoparticles have not been systematically investigated as their impact on the environment has not been under the scrutiny of regulatory control ([@b20-ijn-3-533]; [@b17-ijn-3-533]).

Titanium dioxide (TiO~2~) has been increasingly employed in a variety of industrial applications including production of paper, plastics, cosmetics, and paints ([@b33-ijn-3-533]) and TiO~2~ micro- and nanoparticles were classified as comparatively inert ([@b4-ijn-3-533]; [@b2-ijn-3-533]; [@b11-ijn-3-533]). These ubiquitous applications lead to increasing human exposure to these nanoparticles. [@b8-ijn-3-533] noted that pleural disease was present in 17% of the workers exposed to TiO~2~ and was associated with the duration of work in titanium manufacturing, even though the health risk resulting from this increased exposure to such nanoparticles both in natural as well as industrial environments has not been comprehensively or systematically assessed. Nevertheless, recent *in vivo* studies in animals have pointed to the possibilities that inhalation and other lung exposure to TiO~2~ particles can induce inflammatory responses in lung tissue and even cytotoxicity in lung cells although the degree of inflammatory responses and cytotoxicity elicited depends critically on particle size and its surface chemistry ([@b26-ijn-3-533]; [@b6-ijn-3-533]; [@b28-ijn-3-533]; [@b34-ijn-3-533]; [@b19-ijn-3-533]; [@b35-ijn-3-533]). However, these criteria are still somewhat controversial and remain to be resolved ([@b27-ijn-3-533]; [@b26-ijn-3-533]; [@b19-ijn-3-533]; [@b35-ijn-3-533]).

The few studies on the cytotoxic effects of TiO~2~ nanoparticles on human cell types have been mainly focused on lung or related epithelial cells. For example, [@b32-ijn-3-533] demonstrated human epithelial A549 cells were able to take up TiO~2~ nanoparticles (50 nm diameter) by endocytosis when exposed to them at 40 μg/mL. Subsequently, [@b31-ijn-3-533] found that these human lung epithelial (A549) cells could take up a range of TiO~2~ nanoparticles (20--300 nm) and exposure to these nanoparticles triggered inflammatory responses from the cells. In parallel, [@b19-ijn-3-533] noted similar inflammatory responses elicited from A549 cells by exposure to TiO~2~ nanoparticles and exposure to TiO~2~ nanoparticles also induced dose-related apoptotic damage in such cells ([@b21-ijn-3-533]). Furthermore, anatase TiO~2~ nanoparticles were more cytotoxic than rutile TiO~2~ nanoparticles to the A549 cells ([@b30-ijn-3-533]). Exposure of BEAS-2B cells, another human bronchial epithelial cell line, to TiO~2~ nanoparticles likewise resulted in oxidative damage to those cells ([@b10-ijn-3-533]). Furthermore, exposure to TiO~2~ nanoparticles (\<100 nm in diameter) induced genotoxicity and cytotoxicity in cultured human lymphoblastoid (WIL2-NS) cells ([@b33-ijn-3-533]).

Consistent with the findings of effects of TiO~2~ nanoparticles on human lung epithelial cells are the limited investigation employing non-human mammalian cells. Exposure of Syrian hamster embryo fibroblasts to ultrafine TiO~2~ particles (≤20 nm) resulted in micronuclei and apoptosis in those cells ([@b23-ijn-3-533]) and TiO~2~ nanoparticles (40 nm) also induced cytotoxicity in rat liver cells ([@b12-ijn-3-533]). Nevertheless, the effects of TiO~2~ nanoparticles on human or non-human mammalian neural cells are largely unknown ([@b16-ijn-3-533], [@b17-ijn-3-533]).

Airborne toxic metallic substances can enter the brain directly via retrograde transport through the olfactory nerve and olfactory bulb and/or via transport across the blood-brain barrier subsequent to lung absorption ([@b14-ijn-3-533]). Astrocytes form end-feet around the brain capillary endothelium, which is the main cellular component of the blood-brain barrier ([@b1-ijn-3-533]). Thus, metallic oxide nanoparticles could reach the brain via these two routes. Again, the putative cytotoxic effects of such nanoparticles on neural cells have not been elucidated ([@b16-ijn-3-533], [@b17-ijn-3-533]).

We hypothesized that TiO~2~ nanoparticles can exert differential cytotoxic effects on various human cell types. Thus, to test our hypothesis, this study was initiated to compare the putative cytotoxic effects of TiO~2~ micro- and nanoparticles on human astrocytoma (astrocytes-like) U87 cells and on normal human fibroblasts employing established cytotoxicity testing approaches ([@b29-ijn-3-533]; [@b13-ijn-3-533], [@b15-ijn-3-533]; [@b18-ijn-3-533]; [@b22-ijn-3-533]; [@b7-ijn-3-533]). Furthermore, we have compared the effects of magnesium oxide (MgO) and zinc oxide (ZnO) nanoparticles with those of TiO~2~ nanoparticles on U87 cells to determine if the effects of metallic oxide nanoparticles of essential elements (eg, Mg and Zn) are similar to those of metallic oxide nanoparticles of nonessential elements (eg, Ti).

Materials and methods
=====================

Materials
---------

Titanium dioxide (TiO~2~) microparticles (STREM Chemicals, Newburyport, MA, USA; Cat. \#93-2206; synonym, beta-Rutile; \>99% pure; 1--1.3 μ), TiO~2~, anatase, nanoparticles (Sigma-Aldrich, St. Louis, MO, USA; Cat. \#637254; nanopowder, \<25 nm particle size, 99.7% (metals basis)), MgO nanopowder (Sigma-Aldrich; Cat. \#549649; nanopowder, \<50 nm particle size), and ZnO nanopowder (Sigma-Aldrich; Cat. \#544906; nanopowder, \<100 nm particle size) were dispersed in 100 mL of sterile saline in a sealed conical flask and the suspension stirred at ambient temperature overnight before being employed to be diluted to the specified concentrations for treatment of cells (see below). Dulbecco's minimum essential medium (DMEM) and other chemicals (usually of analytical grade) were purchased from Sigma-Aldrich. The ApoScreen^TM^ Annexin V-FITC Kit (Cat. \#10010-02) was purchased from Southern Biotechnology Associates, Inc. (Birmingham, AL 35260, USA).

Cells and culture conditions
----------------------------

Human astrocytoma U87 (astrocytes-like) cells and human fibroblasts (HFF-1) were obtained from ATCC (Manassas, VA, USA) and were cultured in DMEM, supplemented with 10% (v/v) (and in the case of HFF-1 cells, 15% (v/v)) fetal bovine serum and were incubated at 37 °C and 5% (v/v) CO~2~ as described previously ([@b18-ijn-3-533]).

Cell viability assay
--------------------

Cellular viability was determined using the MTT assay ([@b18-ijn-3-533]). Cells were seeded with equal density in each well of 96 well plates and allowed to attach to the bottom of each well for 60--90 minutes. Cells were then treated in 96-well plates with specified concentrations of TiO~2~ micro-or nanoparticles or ZnO nanoparticles or MgO nanoparticles for 48 hours at 37 °C. At the end of the treatment period, MTT dye (0.5% (w/v) in phosphate-buffered saline) was added to each well and the plates (set one) were incubated for another 4 hours at 37 °C. Purple colored insoluble formazan crystals in viable cells were dissolved using dimethyl sulfoxide (DMSO, 100 μL per well). To prevent the micro- and nanoparticles from interfering with this assay (data not shown), the formazan material dissolved in DMSO in each well of each plate was quantitatively transferred to an empty well in another plate (set two) while the material in DMSO from a well with micro- or nanoparticles only (ie, without cells) served as the corresponding control. Subsequently, the absorbance of the content of each well in each plate (set two) was measured at 567 nm using a multi-detection microplate reader (Bio-Tek Synergy HT, Winooski, VT, USA).

Cellular morphology
-------------------

The putative changes in the morphology of U87 cells treated with specified concentrations of TiO~2~ micro- or nanoparticles for 48 hours at 37 °C as described above were compared to that of corresponding untreated cells by light microscopy. Bright field images of cells were acquired using a Leica light microscope (Leica DM IRB, Bannockburn, IL, USA) equipped with a digital camera (Leica DFC 300FX) ([@b7-ijn-3-533]).

Cell damage and assay for necrosis
----------------------------------

Cell damage was determined by monitoring lactate dehydrogenase (LDH) release from cells into the culture medium: LDH release from cells is a marker of necrotic cell damage and cell death ([@b29-ijn-3-533]; [@b13-ijn-3-533], [@b15-ijn-3-533]). U87 cells were cultured in DMEM in 75 cm^2^ flasks until they were ∼70% confluent and then treated with different concentrations of TiO~2~ micro- or nanoparticles for 48 hours at 37 °C. Subsequently, the culture medium from each flask was removed and kept at −70 °C until they were used for assaying LDH activity therein. LDH activity released by cells into the culture medium was assayed by the procedure of [@b5-ijn-3-533].

Determination of necrotic and apoptotic cells
---------------------------------------------

U87 cells were seeded at 5,000 cells per well onto a 48-well plate and were allowed 2--4 hours for them to attach to the bottom of the well. The cells were then treated with TiO~2~ micro- or nanoparticles at 1, 10, or 50 μg/mL for 48 hours at 37 °C as described above. Then the medium was removed from each well and the cell washed with phosphate-buffered saline. Subsequently, 200 μl of the binding buffer from the ApoScreen^TM^ Annexin V-FITC Kit (Southern Biotechnology Associates, Inc.), followed by 10 μl of Annexin-V and 10 μl of propidium iodide (PI) from the same kit. After adding the dyes into each well, the plate was incubated at 37 °C for 30 minutes. Afterwards, images of fluorescent cells were captured using a fluorescence microscope (Leica DM IRB) equipped with a digital camera (Leica DFC 300 FX). The color photomicrographs were digitally converted to grey-scale images for presentation herein. The green Annexin-V dye stained apoptotic cells whereas red-fluorescent PI dye stained necrotic cells ([@b38-ijn-3-533]).

Statistical analyses of data
----------------------------

Results are presented as mean ± standard error of the mean (SEM) of 6--9 determinations in each experiment. Each experiment was performed at least three times. Data analysis was carried out by one-way analyses of variance (ANOVA), followed by post-hoc Student--Newman--Keuls test for multiple comparisons using the software KaleidaGraph version 4 (Synergy Software, Reading, PA, USA). Significance level was set at P \< 0.05.

Results
=======

Effects of TiO~2~ micro- and nanoparticles on survival of human astrocytoma (astrocytes-like) U87 cells
-------------------------------------------------------------------------------------------------------

Exposure of U87 cells for 48 hours to both TiO~2~ micro- and nanoparticles at concentrations below 1.0 μg/mL did not affect their survival as determined by the MTT assay ([Figure 1](#f1-ijn-3-533){ref-type="fig"}). However, at concentrations higher than 1 μg/mL, both TiO~2~ micro- and nanoparticles induced concentration-related (and time-dependent up to 72 hours; data not shown) decrease in survival of U87 cells, with similar IC~50~ (ie, concentration that gave rise to 50% decrease in cell survival) values of ∼40 and 34 μg/mL, respectively ([Figure 1](#f1-ijn-3-533){ref-type="fig"}). At the highest concentration of both micro- and nanoparticles employed (ie, 100 μg/mL), U87 cell survival decreased to less than 30% of those of untreated cells (ie, control) ([Figure 1](#f1-ijn-3-533){ref-type="fig"}). It is interesting to note that irrespective of their sizes, the dose-effect relations of micro- and nanoparticles on U87 cells were very similar.

Effects of ZnO and MgO nanoparticles on survival of human astrocytoma (astrocytes-like) U87 cells
-------------------------------------------------------------------------------------------------

To assess if other metallic oxide nanoparticles may exert cytotoxicity on human neural cells similar to those of TiO~2~ micro- and nanoparticles, we also studied the effects of nanoparticles of two oxides of essential metals, namely ZnO and MgO, on U87 cells. Exposure of these cells to ZnO for 48 hours at concentrations higher than 1 μg/mL induced a concentration-related decreases in cell survival, with an IC~50~ of ∼11 μg/mL ([Figure 2](#f2-ijn-3-533){ref-type="fig"}); at concentrations of ZnO nanoparticles higher than 20 μg/mL, cell survival decreased to less than 5% of that of untreated (ie control) cells ([Figure 2](#f2-ijn-3-533){ref-type="fig"}). In contrast with the effect of ZnO nanoparticles, treatment of U87 cells with MgO nanoparticles for 48 hours did not significantly decrease their survival until the concentrations were higher than 50 μg/mL ([Figure 2](#f2-ijn-3-533){ref-type="fig"}). Nevertheless, even at the highest concentration employed (ie, 100 μg/mL), MgO nanoparticles only did induce approximately 35% decrease in U87 cell survival, indicating that at the concentration range employed, MgO nanoparticles were less cytotoxic to these cells than ZnO nanoparticles ([Figure 2](#f2-ijn-3-533){ref-type="fig"}).

Effects of TiO~2~ micro- and nanoparticles on survival of human fibroblasts (HFF-1)
-----------------------------------------------------------------------------------

To determine if the effects of TiO~2~ micro- and nanoparticles on neural cells were similar to their effects on nonneural cells, we also examined the effects of these metallic oxide micro- and nanoparticles on normal human fibroblasts (HFF-1 cells). Exposure of HFF-1 cells for 48 hours to both TiO~2~ micro- and nanoparticles induced significant decreases in cell survival at concentrations higher than 1 μg/mL ([Figure 3](#f3-ijn-3-533){ref-type="fig"}). At concentrations between 1 and 10 μg/mL, TiO~2~ nanoparticles were more potent in lowering the survival of these cells whereas when the concentrations were increased beyond 10 μg/mL, both the micro- and the nanoparticles were equally effective in lowering the survival of the HFF-1 cells, except at the highest level employed (ie, 100 μg/mL), where again the nanoparticles were more effective than the microparticles in lowing the survival of these cells ([Figure 3](#f3-ijn-3-533){ref-type="fig"}). When these cells were treated with TiO~2~ micro- and nanoparticles at 100 μg/mL for 48 hours, their survival decreased to less than 40% and 30%, respectively, of that of untreated (ie, control) HFF-1 cells ([Figure 3](#f3-ijn-3-533){ref-type="fig"}). Nevertheless, irrespective of their sizes, the IC~50~ values for both TiO~2~ micro- and nanoparticles in lowering the survival of HFF-1 cells were about the same: they were ∼40 μg/mL ([Figure 3](#f3-ijn-3-533){ref-type="fig"}).

Effects of TiO~2~ micro- and nanoparticles on lactate dehydrogenase release from human astrocytoma (astrocytes-like) U87 cells into the medium
----------------------------------------------------------------------------------------------------------------------------------------------

To further elucidate the cytotoxic effects of TiO~2~ micro- and nanoparticles on U87 cells, we determine the effects of these two types of particles on inducing lactate dehydrogenase (LDH) release from U87 cells into the medium because LDH release from cells is a marker of necrotic cell damage and cell death ([@b29-ijn-3-533]; [@b13-ijn-3-533], [@b15-ijn-3-533]). Treatment of U87 cells with TiO~2~ micro- or nanoparticles at 1 and 10 μg/mL did not induce any increases in LDH from these cells (data not shown). Treatment of these cells with TiO~2~ micro- or nanoparticles at 50 μg/mL for 48 hours only elicited modest increases (\<25%) in LDH release from these cells (data not shown), suggesting that even at this higher concentration, both TiO~2~ micro- and nanoparticles only induced minimal necrotic damage to these cells.

Cell death mechanisms underlying the effects of TiO~2~ micro- and nanoparticles on human astrocytoma (astrocytes-like) U87 cells
--------------------------------------------------------------------------------------------------------------------------------

To further elucidate the cell death mechanism(s) underlying the effects of these micro- and nanoparticles on human astrocytoma (astrocytes-like) U87 cells, we examined the cellular morphology of these cells under bright field light microscopy after the cells had been exposed to specified concentration of TiO~2~ micro- or nanoparticles. Furthermore, employing fluorescence microscopy, we also examined the treated cells stained with PI and Annexin-V. We chose the concentrations of TiO~2~ micro- and nanoparticles at 1, 10, and 50μg/mL because they fell in the range that was above and below the respective IC~50~ values of the particles in inducing cell death (see [Figure 1](#f1-ijn-3-533){ref-type="fig"}).

As noted under bright field microscopy, the control (ie, untreated) U87 cells showed "healthy" morphology with one or more processes extended from their cell bodies ([Figure 4A](#f4-ijn-3-533){ref-type="fig"}). After treatment with either TiO~2~ microparticles ([Figure 4B](#f4-ijn-3-533){ref-type="fig"}) or nanoparticles ([Figure 4E](#f4-ijn-3-533){ref-type="fig"}) at 1 μg/mL for 48 hours, the nuclei of the treated U87 cells became more prominent while there were fewer processes extended from their cell bodies. At the same time, the TiO~2~ microparticles and nanoparticles appeared to aggregate and some aggregated on or around the U87 cells ([Figures 4B and 4E](#f4-ijn-3-533){ref-type="fig"}). After U87 cells had been treated with 10 and 50 μg/mL of TiO~2~ microparticles ([Figures 4C and 4D](#f4-ijn-3-533){ref-type="fig"}) or nanoparticles ([Figures 4F and 4G](#f4-ijn-3-533){ref-type="fig"}), few intact cells were observed although some particle aggregates were noted to be around or on cells. Both micro- and nanoparticles appeared to form both small and larger aggregates, the number of which appeared to increase as the particle concentration was increased ([Figures 4C, 4D, 4F, and 4G](#f4-ijn-3-533){ref-type="fig"}). Thus, the bright field microscopy data are consistent with cell survival data ([Figure 1](#f1-ijn-3-533){ref-type="fig"}), suggesting that when U87 cells were treated with increasing concentrations of TiO~2~- microparticles or nanoparticles, there was a progressive decrease in the number of live U87 cells.

As noted under fluorescence microscopy, there were very few control (ie untreated) U87 cells stained with PI ([Figure 5A](#f5-ijn-3-533){ref-type="fig"}), indicating that there were very few necrotic cells among the population of untreated U87 cells examined. After U87 cells had been treated with progressively increased concentrations of TiO~2~ microparticles (1, 10, or 50 μg/mL) for 48 hours, the number of cells stained with PI progressively increased ([Figures 5B--5D](#f5-ijn-3-533){ref-type="fig"}), suggesting that the number of necrotic cells increased with increases in treatment levels. Similarly, the number of cells stained with PI likely progressively increased ([Figures 5E--5G](#f5-ijn-3-533){ref-type="fig"}) with increases in the treatment level of TiO~2~ nanoparticles (1, 10, or 50 μg/mL for 48 hours) although the effects of the nanoparticles were somewhat less marked than those of the microparticles ([Figures 5B--5D](#f5-ijn-3-533){ref-type="fig"}). It should be pointed out that we noticed that both TiO~2~ microparticles and nanoparticles interacted with the PI dye to yield some fluorescence in the absence of U87 cells, although their fluorescence was minimal (data not shown) compared those noted in the treated cells.

As observed under fluorescence microscopy, very few control (ie, untreated) U87 cells were stained with Annexin-V ([Figure 6A](#f6-ijn-3-533){ref-type="fig"}), indicating that there were very few apoptotic cells within that population. After U87 cells had been treated with progressively increased concentrations of TiO~2~ microparticles (1, 10, or 50 μg/mL) for 48 hours, the number of cells stained with Annexin-V progressively increased ([Figures 6B--6D](#f6-ijn-3-533){ref-type="fig"}), suggesting that the number of apoptotic cells increased with increases in treatment levels. It is interesting to note that not all the treated cells showed uniformed staining although the staining intensity increased as the treatment level increased ([Figures 6B--6D](#f6-ijn-3-533){ref-type="fig"}) suggesting that the microparticle-induced apoptosis was not synchronized in those populations of U87 cells. Similarly, after U87 cells had been treated with progressively increased concentrations of TiO~2~ nanoparticles (1, 10, or 50 μg/mL) for 48 hours, the number of cells stained with Annexin-V progressively increased ([Figures 6E--6G](#f6-ijn-3-533){ref-type="fig"}), suggesting that the number of apoptotic cells increased with increases in treatment levels. However, the level of Annexin-V staining in the nanoparticles-treated cells was less marked compared to those in cells treated with corresponding levels of microparticles ([Figures 6B--6D](#f6-ijn-3-533){ref-type="fig"}). Again, we noticed that both TiO~2~ microparticles and nanoparticles interacted with the Annexin-V dye to yield some fluorescence in the absence of U87 cells, although their fluorescence was minimal (data not shown). Furthermore, it was interesting to observe that many U87 cells treated with TiO~2~ microparticles or nanoparticles stained with Annexin-V also co-stained with PI (compare [Figures 5 and 6](#f5-ijn-3-533){ref-type="fig"}) while in the same field there were few treated cells that stained only with Annexin-V or PI, suggesting either apoptosis and necrosis mechanisms were co-occurring in those cells or those cells exhibited another cell death mechanism that shares some common features with apoptosis and necrosis (ie, hybrid mechanism; [@b3-ijn-3-533]; [@b36-ijn-3-533]; [@b9-ijn-3-533]).

Discussion
==========

To our knowledge our studies are the first to demonstrate the cytotoxic effects of TiO~2~ micro- and nanoparticles on human neural cells (namely U87 astrocytoma cells) and to compare those effects with the effects of ZnO and MgO nanoparticles on the same cell type. At the same time we also contrasted the cytotoxic effects of TiO~2~ micro- and nanoparticles on human U87 cells (astrocytes-like) and on normal human fibroblasts (HFF-1 cells). Furthermore, we have also determined the cell death mechanisms underlying the cytotoxic effects of TiO~2~ micro- and nanoparticles on U87 cells. We found that TiO~2~ micro- and nanoparticles appeared to induce U87 cells to undergo both apoptosis and necrosis or a cell death mechanism that may contain features of both apoptosis and necrosis (see below).

Because the putative cytotoxic effects of TiO~2~ micro- and nanoparticles on human cells (especially human neural cells) have not been systematically elucidated, with the exception of human lung epithelial (A549) cells ([@b32-ijn-3-533]; [@b31-ijn-3-533]; [@b19-ijn-3-533]; [@b21-ijn-3-533]), we have examined the effects of TiO~2~ micro- and nanoparticles on human astrocytoma (astrocytes-like) U87 cells and normal human fibroblasts (HFF-1 cells) employing the MTT cell survival assay ([@b13-ijn-3-533], [@b15-ijn-3-533]; [@b18-ijn-3-533]; [@b22-ijn-3-533]; [@b7-ijn-3-533]). Our results demonstrate that in a concentration range similar to those employed in human lung (A549) cells ([@b32-ijn-3-533]), treatment of human astrocytoma (astrocytes-like) U87 cells with TiO~2~ microparticles or nanoparticles at levels higher than 1 μg/mL for 48 hours induced a concentration-related lowering of cell survival, with IC~50~ values of 30--40 μg/mL ([Figure 1](#f1-ijn-3-533){ref-type="fig"}). At the highest level of both TiO~2~ microparticles and nanoparticles investigated (ie, 100 μg/mL), the survival of U87 cells decreased to less than 30% ([Figure 1](#f1-ijn-3-533){ref-type="fig"}). Similarly, exposure of normal human fibroblasts (HFF-1 cells) to both TiO~2~ microparticles and nanoparticles in the same concentration range also induced a dose-related decrease in cell survival, with IC~50~ values of \~40 μg/mL ([Figure 3](#f3-ijn-3-533){ref-type="fig"}) although at the lower concentration range of 1 to 10 μg/mL, TiO~2~ nanoparticles were more effective than the microparticles in lowering the survival of human fibroblasts (HFF-1 cells) ([Figure 3](#f3-ijn-3-533){ref-type="fig"}). Thus, these results suggest that both TiO~2~ microparticles and nanoparticles, despite the difference in their sizes, are equally effective in inducing cell death in human neural (ie, U87) cells and normal fibroblasts ([Figures 1](#f1-ijn-3-533){ref-type="fig"} and [3](#f3-ijn-3-533){ref-type="fig"}). While the cytotoxic effects of TiO~2~ microparticles and nanoparticles on human cell types other than those discussed above are largely unknown, there is one study noting that exposure to TiO~2~ nanoparticles induced cytotoxicity and genotoxicity in human lymphoblastoid (WIL2-NS) cells ([@b33-ijn-3-533]). Furthermore, [@b12-ijn-3-533] reported TiO~2~ nanoparticles induced cytotoxicity in rat liver cells.

As far as we are aware, we are also the first to compare the cytotoxic effects of metallic oxide nanoparticles of essential metals (namely zinc and magnesium) with those of a nonessential metal (ie, Ti) on human neural (namely U87 astrocytoma) cells. It is interesting to note that of the three metallic oxide nanoparticles, ZnO nanoparticles were the most effective ([Figure 3](#f3-ijn-3-533){ref-type="fig"}), TiO~2~ nanoparticles were the next most effective ([Figure 1](#f1-ijn-3-533){ref-type="fig"}), and MgO nanoparticles the least effective ([Figure 3](#f3-ijn-3-533){ref-type="fig"}) in inducing cell death in U87 cells. In this context, it is relevant to observe that, in contrast with their effect on human neural U87 cells, ZnO nanoparticles (\~13 nm) are not effective in lowering the survival of primary human T cells at concentrations ≤5 mM ([@b25-ijn-3-533]). Clearly, additional work is required to further elucidate the cytotoxic effects of ZnO and other metallic oxide nanoparticles on these and other human cell types.

Because cell death mechanisms underlying the effects of TiO~2~ microparticles and nanoparticles on neural cells are unknown, we have investigated these putative mechanisms in human astrocytoma (astrocytes-like) U87 cells. We found that a fraction of U87 cells treated with TiO~2~ microparticles or nanoparticles showed Annexin-V staining, a marker of apoptosis, and the cellular staining was increased with increases in the treatment concentrations of the microparticles or nanoparticles ([Figure 6](#f6-ijn-3-533){ref-type="fig"}). This finding indicates that treatment of U87 cells with either TiO~2~ microparticles or nanoparticles, irrespective of their sizes, induces apoptosis in those cells: this observation is consistent with that of [@b21-ijn-3-533] who showed that treatment of human lung epithelial (A549) cells with TiO~2~ nanoparticles induce dose-related apoptotic damage in those cells.

In our studies ([Figure 5](#f5-ijn-3-533){ref-type="fig"}), we also noted that a fraction of U87 cells treated with TiO~2~ microparticles or nanoparticles showed PI staining, a marker of necrosis, and the cellular staining was increased with increases in the treatment concentrations of the microparticles or nanoparticles ([Figure 5](#f5-ijn-3-533){ref-type="fig"}). Thus, this observation demonstrates that treatment with TiO~2~ microparticles or nanoparticles also induces necrotic cell death in human neural (ie, U87) cells. However, a third and larger fraction of U87 cells treated with TiO~2~ microparticles or nanoparticles showed co-staining with both PI and Annexin-V (compare [Figures 5](#f5-ijn-3-533){ref-type="fig"} and [6](#f6-ijn-3-533){ref-type="fig"}). There are several mechanistic explanations to account for the co-staining of PI and Annexin-V in the treated U87 cells. (i) Both apoptosis and necrosis could be co-occurring in the U87 cells treated with TiO~2~ microparticles or nanoparticles. Co-existence of apoptosis and necrosis in neural cells is known to occur: for example, in the developing brain, focal ischemia induces cell death with overt apoptotic characteristics co-existing with some features of necrosis ([@b36-ijn-3-533]). (ii) Paraptosis, a new type of cell death independent of caspases (Sperandio et al 2000; [@b3-ijn-3-533]), could occur in the U87 cells treated with TiO~2~ microparticles or nanoparticles because paraptotic cells are stained with PI (Sperandio et al 2000). (iii) The apoptosis-like and necrosis-like programmed cell death as postulated by [@b3-ijn-3-533] could occur in the U87 cells treated with TiO~2~ microparticles or nanoparticles because of our observation that the cells were co-stained with PI and Annexin-V, yet the lactate dehydrogenase release from such cells were minimal (see Results section above). (iv) There remains the possibility that we may be encountering a totally new mode of cell death mechanism in the U87 cells treated with TiO~2~ microparticles or nanoparticles. After all, it has become increasingly clear that the "classical" distinction of three cell death types -- type I (apoptosis), type II (autophagy), and type III (necrosis) -- is inadequate to account for all the observed phenomena of cell death ([@b3-ijn-3-533]; [@b9-ijn-3-533]). Consequently, only additional studies will elucidate as to which of the cell death mechanisms proposed above can accurately depict the mechanisms induced in U87 cells by treatment with TiO~2~ microparticles or nanoparticles.

Conclusion and implications
===========================

Our studies are the first to demonstrate that exposure of human neural (ie, astrocytoma U87) cells to TiO~2~ micro- and nanoparticles induces a concentration-related increases in cell death in this cell type. We also found similar dose-related effects of these micro- and nanoparticles in inducing cell death in normal human fibroblasts (HFF-1 cells). In comparing the effects of metallic oxide nanoparticles of essential metals (ie, ZnO and MgO) and nonessential metals (ie, TiO~2~), we noted ZnO nanoparticles are the most effective, TiO~2~ nanoparticles the second most effective, and MgO nanoparticles the least effective in inducing decreases in survival of human neural (ie astrocytoma U87) cells.

We observed that treatment of human astrocytoma (astrocytes-like) U87 cells with TiO~2~ microparticles or nanoparticles induces several modes of cell death in these cells, including apoptosis, necrosis, and possibly a "new" type of cell death that is apoptosis-like and necrosis-like. Thus, these interesting phenomena merit further investigation to elucidate the underlying pathophysiological and molecular mechanisms.

As alluded to above, the industrial use of metallic oxide nanoparticles (including those of TiO~2~) in wide diversity of applications has been expanding exponentially, leading to increasing occupational and other environmental exposure of these nanoparticles to human and other species. Because airborne toxic metallic substances can enter the brain directly via retrograde transport through the olfactory nerve into the rest of the brain and/or via transport across the blood-brain barrier, the results of our studies may have toxicological and other pathophysiological implications in exposure of human and other mammalian species to TiO~2~ micro- and nanoparticles in particular, and to metallic oxide nanoparticles in general. Consequently, metallic oxides such as TiO~2~, that is used in dental and other implants ([@b37-ijn-3-533]; [@b24-ijn-3-533]) because the material appears to be biologically compatible, may not be as benign as one previously presupposed. Clearly, this area of nanotoxicity deserves further systematic investigation.

Our studies were supported by an USAMRMC Project Grant (Contract \#W81XWH-07-2-0078) and NIH Grant \#P20 RR016454 from the Idaho INBRE Program of the National Center for Research Resources.

![Effects of TiO~2~ micro- and nanoparticles on survival of human astrocytoma (astrocytes-like) U87 cells.\
**Notes:** Values are mean ± SEM of 6--9 determinations. U87 cells treated with TiO~2~ microparticles are marked with open squares and those treated with TiO~2~ nanoparticles are marked with open circles. Values marked with **a** and **b** are significantly different (p \< 0.05, by ANOVA and post-hoc Student--Newman--Keuls test) from corresponding mean value in control (ie, untreated) cells.\
**Abbreviations:** ANOVA, analysis of variance; SEM, standard error of mean; TiO~2~, titanium dioxide.](ijn-3-533f1){#f1-ijn-3-533}

![Effects of ZnO and MgO nanoparticles on human astrocytoma (astrocytes-like) U87 cells.\
**Notes:** Values are mean ± SEM of 6--9 determinations. U87 cells treated with ZnO nanoparticles are marked with open squares and those treated with MgO nanoparticles are marked with open circles. Values marked with **a** and **b** are significantly different (p \< 0.05, by ANOVA and post-hoc Student--Newman--Keuls test) from corresponding mean value in control (ie, untreated) cells.\
**Abbreviations:** ANOVA, analysis of variance; MgO, magnesium oxide; SEM, standard error of mean; ZnO, zinc oxide.](ijn-3-533f2){#f2-ijn-3-533}

![Effects of TiO~2~ micro- and nanoparticles on survival of human fibroblasts (HFF-1).\
**Notes:** Values are mean ± SEM of 6--9 determinations. HFF-1 cells treated with TiO~2~ microparticles are marked with open squares and those treated with TiO~2~ nanoparticles are marked with open circles. Values marked with **a** and **b** are significantly different (p \< 0.05, by ANOVA and post-hoc Student--Newman--Keuls test) from corresponding mean value in control (ie, untreated) cells.\
**Abbreviations:** ANOVA, analysis of variance; SEM, standard error of mean; TiO~2~, titanium dioxide.](ijn-3-533f3){#f3-ijn-3-533}

![Cellular morphology of human astrocytoma (astrocytes-like) U87 cells after exposure to TiO~2~ microparticles or nanoparticles.\
**Notes:** U87 cells were treated with TiO~2~ microparticles or nanoparticles for 48 hours and then examined with bright field light microscopy at a magnification of 100. The treatments were: **A**) control (ie, untreated) U87 cells; **B**) cells treated with 1 μg/mL TiO~2~ microparticles; **C**) cells treated with 10 μg/mL TiO~2~ microparticles; **D**) cells treated with 50 μg/mL TiO~2~ microparticles; **E**) cells treated with 1 μg/mL TiO~2~ nanoparticles; **F**) cells treated with 10 μg/mL TiO~2~ nanoparticles; and **G**) cells treated with 50 μg/mL TiO~2~ nanoparticles.\
**Abbreviation:** TiO~2~, titanium dioxide.](ijn-3-533f4){#f4-ijn-3-533}

![Increases in PI-stained cells after exposure of human astrocytoma (astrocytes-like) U87 cells to TiO~2~ microparticles or nanoparticles.\
**Notes:** U87 cells were treated with TiO~2~ microparticles or nanoparticles for 48 hours, then stained with PI, and the stained cells were photographed at a magnification of 100. The treatments were: **A**) control (ie, untreated) U87 cells; **B**) cells treated with 1 μg/mL TiO~2~ microparticles; **C**) cells treated with 10 μg/mL TiO~2~ microparticles; **D**) cells treated with 50 μg/mL TiO~2~ microparticles; **E**) cells treated with 1 μg/mL TiO~2~ nanoparticles; **F**) cells treated with 10 μg/mL TiO~2~ nanoparticles; and **G**) cells treated with 50 μg/mL TiO~2~ nanoparticles.\
**Abbreviations:** PI, propidium iodide; TiO~2~, titanium dioxide.](ijn-3-533f5){#f5-ijn-3-533}

![Increases in Annexin-V-stained cells after exposure of human astrocytoma (astrocytes-like) U87 cells to TiO~2~ microparticles or nanoparticles.\
**Notes:** U87 cells were treated with TiO~2~ microparticles or nanoparticles for 48 hours, then stained with Annexin-V, and the stained cells were photographed at a magnification of 100. The treatments were: **A**) control (ie, untreated) U87 cells; **B**) cells treated with 1 μg/mL TiO~2~ microparticles; **C**) cells treated with 10 μg/mL TiO~2~ microparticles; **D**) cells treated with 50 μg/mL TiO~2~ microparticles; **E**) cells treated with 1 μg/mL TiO~2~ nanoparticles; **F**) cells treated with 10 μg/mL TiO~2~ nanoparticles; and **G**) cells treated with 50 μg/mL TiO~2~ nanoparticles. Cells marked with \< or \> were co-stained with both Annexin-V and PI.\
**Abbreviations:** PI, propidium iodide; TiO~2~, titanium dioxide.](ijn-3-533f6){#f6-ijn-3-533}
